Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GPOs Defend Contracting: Groups Do Not Limit Provider Choice

Executive Summary

Group purchasing organizations do not limit the clinical choices of members, AmeriNet VP-Pharmacy Services Allen Dunehew declared during the Health Industry Group Purchasing Association's National Pharmacy Forum Feb. 22 in New Orleans

You may also be interested in...



APP Accounts For 1% Of Premier Drug Spend: Response To Times Article

American Pharmaceutical Partners accounts for 1% of drugs purchased by Premier, the company said

APP Accounts For 1% Of Premier Drug Spend: Response To Times Article

American Pharmaceutical Partners accounts for 1% of drugs purchased by Premier, the company said

GPO investigation goes public

The New York Times is understood to be working on a three-part series focusing on hospital group purchasing organization contracting practices. The Senate Judiciary/Antitrust Subcommittee is expected to hold hearings on the topic this spring. The investigation grew out of allegations by smaller medical device manufacturers that GPO contracts foreclose the market for their products. The Times is understood to have submitted questionnaires to device and pharmaceutical manufacturers on contracting practices as part of its research for the article...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039400

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel